Minimally Invasive Surgical Instrument Market Trends and Forecast
The future of the global minimally invasive surgical instrument market looks promising with opportunities in the hospital & clinic and ambulatory surgery center & clinic markets. The global minimally invasive surgical instrument market is expected to reach an estimated $45.6 billion by 2028 with a CAGR of 7.9% from 2023 to 2028. The major drivers for this market are increasing incidence of chronic disorders, escalating funding towards healthcare research and development, growing concern towards lifestyle-related illnesses, and growing geriatric population across the globe.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Minimally Invasive Surgical Instrument Market by Segment
The study includes trends and forecast for the global minimally invasive surgical instrument market by product, surgery type, end use industry, and region, as follows:
Minimally Invasive Surgical Instrument Market by Product [Shipment Analysis by Value from 2017 to 2028]:
-
Handheld Instruments
-
Inflation Devices
-
Surgical Scopes
-
Cutting Instruments
-
Guiding Devices
-
Electrosurgical & Electrocautery Instruments
-
Other Instruments
Minimally Invasive Surgical Instrument Market by Surgery Type [Shipment Analysis by Value from 2017 to 2028]:
-
Cardiothoracic Surgery
-
Gastrointestinal Surgery
-
Orthopedic Surgery
-
Gynecological Surgery
-
Cosmetic & Bariatric Surgery
-
Urological Surgery
-
Other Surgeries
Minimally Invasive Surgical Instrument Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:
-
Hospitals & Clinics
-
Ambulatory Surgical Centers
-
Others
Minimally Invasive Surgical Instrument Market by Region [Shipment Analysis by Value from 2017 to 2028]:
-
North America
-
Europe
-
Asia Pacific
-
The Rest of the World
List of Minimally Invasive Surgical Instrument Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies minimally invasive surgical instrument companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the minimally invasive surgical instrument companies profiled in this report include:
-
Medtronic
-
Johnson & Johnson
-
Stryker Corporation
-
Abbott Laboratories
-
Boston Scientific Corporation
-
GE Healthcare
-
Intutive Surgical
-
Nuvasive
-
Zimmer Biomet
Minimally Invasive Surgical Instrument Market Insights
-
Lucintel forecasts that handheld instruments will remain the largest segment over the forecast period because these instruments are cost-effective and easy to use and it also helps in minimizing harm to surrounding tissues, thus leading to quicker patient recuperation while mitigating discomfort and other unfavorable outcomes.
-
Hospitals & clinics will remain the largest segment because of the rise in chronic conditions among the elderly population that resulted in an increase in hospital admissions aiming at addressing the chronic aliment issues, as well as increasing initiatives by the governments worldwide to enhance healthcare infrastructure.
-
North America will remain the largest region over the forecast period due to existence of robust healthcare facilities, supportive government reimbursement policies, along with the widespread occurrence of chronic illnesses in this region.
Features of the Minimally Invasive Surgical Instrument Market
-
Market Size Estimates: Minimally invasive surgical instrument market size estimation in terms of value ($B)
-
Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
-
Segmentation Analysis: Minimally invasive surgical instrument market size by various segments, such as by product, surgery type, end use industry, and region
-
Regional Analysis: Minimally invasive surgical instrument market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
-
Growth Opportunities: Analysis on growth opportunities in different by product, surgery type, end use industry, and regions for the minimally invasive surgical instrument market.
-
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the minimally invasive surgical instrument market.
-
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the minimally invasive surgical instrument market size?
Answer: The global minimally invasive surgical instrument market is expected to reach an estimated $45.6 billion by 2028.
Q2. What is the growth forecast for minimally invasive surgical instrument market?
Answer: The global minimally invasive surgical instrument market is expected to grow with a CAGR of 7.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the minimally invasive surgical instrument market?
Answer: The major drivers for this market are increasing incidence of chronic disorders, escalating funding towards healthcare research and development, growing concern towards lifestyle-related illnesses, and growing geriatric population across the globe.
Q4. What are the major segments for minimally invasive surgical instrument market?
Answer: The future of the global minimally invasive surgical instrument market looks promising with opportunities in the hospital & clinic and ambulatory surgery center & clinic markets.
Q5. Who are the key minimally invasive surgical instrument companies?
Answer: Some of the key minimally invasive surgical instrument companies are as follows:
-
Medtronic
-
Johnson & Johnson
-
Stryker Corporation
-
Abbott Laboratories
-
Boston Scientific Corporation
-
GE Healthcare
-
Intutive Surgical
-
Nuvasive
-
Zimmer Biomet
Q6. Which minimally invasive surgical instrument segment will be the largest in future?
Answer: Lucintel forecasts that handheld instruments will remain the largest segment over the forecast period because these instruments are cost-effective and easy to use and it also helps in minimizing harm to surrounding tissues, thus leading to quicker patient recuperation while mitigating discomfort and other unfavorable outcomes.
Q7. In minimally invasive surgical instrument market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to existence of robust healthcare facilities, supportive government reimbursement policies, along with the widespread occurrence of chronic illnesses in this region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.